Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 238

1.

PATHway to success: implementation of a multiprofessional acute trauma healthcare team decreased length of stay and cost in patients with neurological injury requiring tracheostomy.

Perry A, Mallah M, Cunningham KW, Christmas AB, Marrero JJ, Gombar M, Davis M, Miles WS, Jacobs DG, Fischer P, Sing RF, Thomas BW.

J Trauma Acute Care Surg. 2019 Aug 28. doi: 10.1097/TA.0000000000002494. [Epub ahead of print]

PMID:
31464872
2.

A school nurse-led asthma program reduces absences: Evaluation of Easy Breathing for Schools.

Simoneau T, Langton CR, Kuo CL, Marrero J, Gherlone N, Cloutier MM, Hollenbach JP.

Acad Pediatr. 2019 Jul 28. pii: S1876-2859(19)30340-7. doi: 10.1016/j.acap.2019.07.007. [Epub ahead of print]

PMID:
31365880
3.

Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients with Hepatocellular Carcinoma.

Rich NE, Yang JD, Perumalswami PV, Alkhouri N, Jackson W, Parikh ND, Mehta N, Salgia R, Duarte-Rojo A, Kulik L, Rakoski M, Said A, Oloruntoba O, Ioannou GN, Hoteit MA, Moon AM, Rangnekar AS, Eswaran SL, Zheng E, Jou JH, Hanje J, Pillai A, Hernaez R, Wong R, Scaglione S, Samant H, Kapuria D, Chandna S, Rosenblatt R, Ajmera V, Frenette C, Satapathy SK, Mantry P, Jalal P, John BV, Fix OK, Leise M, Lindenmeyer CC, Flores A, Patel N, Jiang ZG, Latt N, Dhanasekaran R, Odewole M, Kagan S, Marrero JA, Singal AG.

Clin Gastroenterol Hepatol. 2019 Jul 26. pii: S1542-3565(19)30786-4. doi: 10.1016/j.cgh.2019.07.042. [Epub ahead of print]

PMID:
31357028
4.

Obesity and Liver Disease: The New Era of Liver Transplantation.

Marrero JA.

Hepatology. 2019 Aug;70(2):459-461. doi: 10.1002/hep.30854. No abstract available.

PMID:
31301077
5.

Oceanographic barriers, divergence, and admixture: Phylogeography and taxonomy of two putative subspecies of short-finned pilot whale.

Van Cise AM, Baird RW, Baker CS, Cerchio S, Claridge D, Fielding R, Hancock-Hanser B, Marrero J, Martien KK, Mignucci-Giannoni AA, Oleson EM, Oremus M, Poole MM, Rosel PE, Taylor BL, Morin PA.

Mol Ecol. 2019 Jun;28(11):2886-2902. doi: 10.1111/mec.15107. Epub 2019 Jun 2.

PMID:
31002212
6.

Design of the Texas Hepatocellular Carcinoma Consortium Cohort Study.

Feng Z, Marrero JA, Khaderi S, Singal AG, Kanwal F, Loo N, Beretta L, Ning J, El-Serag HB.

Am J Gastroenterol. 2019 Mar;114(3):530-532. doi: 10.14309/ajg.0000000000000068.

PMID:
30699099
7.

Validation of a novel model for the early detection of hepatocellular carcinoma.

Hemken PM, Sokoll LJ, Yang X, Dai J, Elliott D, Gawel SH, Lucht M, Feng Z, Marrero JA, Srivastava S, Chan DW, Davis GJ.

Clin Proteomics. 2019 Jan 16;16:2. doi: 10.1186/s12014-018-9222-0. eCollection 2019.

8.

Lack of Benefit and Potential Harm of Induction Therapy in Simultaneous Liver-Kidney Transplants.

AbdulRahim N, Anderson L, Kotla S, Liu H, Ariyamuthu VK, Ghanta M, MacConmara M, Tujios SR, Mufti A, Mohan S, Marrero JA, Vagefi PA, Tanriover B.

Liver Transpl. 2019 Mar;25(3):411-424. doi: 10.1002/lt.25390.

PMID:
30506870
9.

GALAD Score for Hepatocellular Carcinoma Detection in Comparison with Liver Ultrasound and Proposal of GALADUS Score.

Yang JD, Addissie BD, Mara KC, Harmsen WS, Dai J, Zhang N, Wongjarupong N, Ali HM, Ali HA, Hassan FA, Lavu S, Cvinar JL, Giama NH, Moser CD, Miyabe K, Allotey LK, Algeciras-Schimnich A, Theobald JP, Ward MM, Nguyen MH, Befeler AS, Reddy KR, Schwartz M, Harnois DM, Yamada H, Srivastava S, Rinaudo JA, Gores GJ, Feng Z, Marrero JA, Roberts LR.

Cancer Epidemiol Biomarkers Prev. 2019 Mar;28(3):531-538. doi: 10.1158/1055-9965.EPI-18-0281. Epub 2018 Nov 21.

PMID:
30464023
10.

Rationale and design of the Hepatocellular carcinoma Early Detection Strategy study: A multi-center longitudinal initiative of the National Cancer Institute's Early Detection Research Network.

Borges KA, Dai J, Parikh ND, Schwartz M, Nguyen MH, Roberts LR, Befeler AS, Srivastava S, Rinaudo JA, Feng Z, Marrero JA, Reddy KR.

Contemp Clin Trials. 2019 Jan;76:49-54. doi: 10.1016/j.cct.2018.11.008. Epub 2018 Nov 12.

PMID:
30439517
11.

Diagnostic accuracy of MRI with extracellular vs. hepatobiliary contrast material for detection of residual hepatocellular carcinoma after locoregional treatment.

Rimola J, Davenport MS, Liu PS, Brown T, Marrero JA, McKenna BJ, Hussain HK.

Abdom Radiol (NY). 2019 Feb;44(2):549-558. doi: 10.1007/s00261-018-1775-x.

PMID:
30218239
12.

Mailed Outreach Invitations Significantly Improve HCC Surveillance Rates in Patients With Cirrhosis: A Randomized Clinical Trial.

Singal AG, Tiro JA, Murphy CC, Marrero JA, McCallister K, Fullington H, Mejias C, Waljee AK, Pechero Bishop W, Santini NO, Halm EA.

Hepatology. 2019 Jan;69(1):121-130. doi: 10.1002/hep.30129. Epub 2018 Dec 14.

PMID:
30070379
13.

Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma.

Rich NE, Hester C, Odewole M, Murphy CC, Parikh ND, Marrero JA, Yopp AC, Singal AG.

Clin Gastroenterol Hepatol. 2019 Feb;17(3):551-559.e1. doi: 10.1016/j.cgh.2018.05.039. Epub 2018 May 31.

PMID:
29859983
14.

Efficacy and Safety of Curcumin in Treatment of Intestinal Adenomas in Patients With Familial Adenomatous Polyposis.

Cruz-Correa M, Hylind LM, Marrero JH, Zahurak ML, Murray-Stewart T, Casero RA Jr, Montgomery EA, Iacobuzio-Donahue C, Brosens LA, Offerhaus GJ, Umar A, Rodriguez LM, Giardiello FM.

Gastroenterology. 2018 Sep;155(3):668-673. doi: 10.1053/j.gastro.2018.05.031. Epub 2018 May 23.

15.

Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.

Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, Roberts LR, Heimbach JK.

Hepatology. 2018 Aug;68(2):723-750. doi: 10.1002/hep.29913. No abstract available.

PMID:
29624699
16.

Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.

Tzartzeva K, Obi J, Rich NE, Parikh ND, Marrero JA, Yopp A, Waljee AK, Singal AG.

Gastroenterology. 2018 May;154(6):1706-1718.e1. doi: 10.1053/j.gastro.2018.01.064. Epub 2018 Feb 6.

17.

Risk Factors for Falls Among Older Adults Following Transition From Nursing Home to the Community.

Marrero J, Fortinsky RH, Kuchel GA, Robison J.

Med Care Res Rev. 2019 Feb;76(1):73-88. doi: 10.1177/1077558717697012. Epub 2017 Mar 6.

PMID:
29148330
18.

Effect of hospital safety net designation on treatment use and survival in hepatocellular carcinoma.

Mokdad AA, Murphy CC, Pruitt SL, Mansour JC, Marrero JA, Singal AG, Yopp AC.

Cancer. 2018 Feb 15;124(4):743-751. doi: 10.1002/cncr.31066. Epub 2017 Oct 26.

19.

Direct-acting antivirals and recurrence of hepatocellular carcinoma.

Marrero JA, Singal AG.

Liver Transpl. 2017 Sep;23(9):1099-1100. doi: 10.1002/lt.24822. No abstract available.

20.

Reply.

Atiq O, Tiro J, Yopp AC, Muffler A, Marrero JA, Parikh ND, Murphy C, McCallister K, Singal AG.

Hepatology. 2017 Sep;66(3):1002-1003. doi: 10.1002/hep.29286. Epub 2017 Jul 31. No abstract available.

21.

Expansion of Criteria for Liver Transplantation in Hepatocellular Carcinoma: Better Patient Selection or a Slippery Slope?

Yopp AC, Marrero JA, Singal AG.

Ann Surg Oncol. 2017 Jul;24(7):1758-1760. doi: 10.1245/s10434-017-5802-x. Epub 2017 Mar 17. No abstract available.

PMID:
28315062
22.

Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine Transaminase.

Yang JD, Dai J, Singal AG, Gopal P, Addissie BD, Nguyen MH, Befeler AS, Reddy KR, Schwartz M, Harnois DM, Yamada H, Gores GJ, Feng Z, Marrero JA, Roberts LR.

Cancer Epidemiol Biomarkers Prev. 2017 Jul;26(7):1085-1092. doi: 10.1158/1055-9965.EPI-16-0747. Epub 2017 Mar 3.

23.

Changes in the Glycosylation of Kininogen and the Development of a Kininogen-Based Algorithm for the Early Detection of HCC.

Wang M, Sanda M, Comunale MA, Herrera H, Swindell C, Kono Y, Singal AG, Marrero J, Block T, Goldman R, Mehta A.

Cancer Epidemiol Biomarkers Prev. 2017 May;26(5):795-803. doi: 10.1158/1055-9965.EPI-16-0974. Epub 2017 Feb 21.

24.

Hepatocellular Carcinoma Screening Associated with Early Tumor Detection and Improved Survival Among Patients with Cirrhosis in the US.

Singal AG, Mittal S, Yerokun OA, Ahn C, Marrero JA, Yopp AC, Parikh ND, Scaglione SJ.

Am J Med. 2017 Sep;130(9):1099-1106.e1. doi: 10.1016/j.amjmed.2017.01.021. Epub 2017 Feb 14.

PMID:
28213044
25.

Vascular Invasion and Metastasis is Predictive of Outcome in Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma.

Mokdad AA, Singal AG, Marrero JA, Zhu H, Yopp AC.

J Natl Compr Canc Netw. 2017 Feb;15(2):197-204.

PMID:
28188189
26.

AASLD guidelines for the treatment of hepatocellular carcinoma.

Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR, Zhu AX, Murad MH, Marrero JA.

Hepatology. 2018 Jan;67(1):358-380. doi: 10.1002/hep.29086. No abstract available.

PMID:
28130846
27.

Editorial: ultrasound surveillance of hepatocellular carcinoma in the 21st century - authors' reply.

Simmons O, Fetzer DT, Yokoo T, Marrero JA, Yopp A, Parikh N, Browning T, Singal AG.

Aliment Pharmacol Ther. 2017 Feb;45(4):562-563. doi: 10.1111/apt.13910. No abstract available.

28.

Outcomes of Simultaneous Liver Kidney Transplantation in Patients With Hepatocellular Carcinoma.

Rich N, Tanriover B, Singal AG, Marrero JA.

Transplantation. 2017 Jan;101(1):e12-e19. doi: 10.1097/TP.0000000000001515.

PMID:
28009759
29.

Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.

Casanova MJ, Chaparro M, García-Sánchez V, Nantes O, Leo E, Rojas-Feria M, Jauregui-Amezaga A, García-López S, Huguet JM, Arguelles-Arias F, Aicart M, Marín-Jiménez I, Gómez-García M, Muñoz F, Esteve M, Bujanda L, Cortés X, Tosca J, Pineda JR, Mañosa M, Llaó J, Guardiola J, Pérez-Martínez I, Muñoz C, González-Lama Y, Hinojosa J, Vázquez JM, Martinez-Montiel MP, Rodríguez GE, Pajares R, García-Sepulcre MF, Hernández-Martínez A, Pérez-Calle JL, Beltrán B, Busquets D, Ramos L, Bermejo F, Barrio J, Barreiro-de Acosta M, Roncedo O, Calvet X, Hervías D, Gomollón F, Domínguez-Antonaya M, Alcaín G, Sicilia B, Dueñas C, Gutiérrez A, Lorente-Poyatos R, Domínguez M, Khorrami S, Muñoz C, Taxonera C, Rodríguez-Pérez A, Ponferrada A, Van Domselaar M, Arias-Rivera ML, Merino O, Castro E, Marrero JM, Martín-Arranz M, Botella B, Fernández-Salazar L, Monfort D, Opio V, García-Herola A, Menacho M, Ramírez-de la Piscina P, Ceballos D, Almela P, Navarro-Llavat M, Robles-Alonso V, Vega-López AB, Moraleja I, Novella MT, Castaño-Milla C, Sánchez-Torres A, Benítez JM, Rodríguez C, Castro L, Garrido E, Domènech E, García-Planella E, Gisbert JP.

Am J Gastroenterol. 2017 Jan;112(1):120-131. doi: 10.1038/ajg.2016.569. Epub 2016 Dec 13.

PMID:
27958281
30.

SIMULTANEOUS LIVER KIDNEY TRANSPLANTATION IN LIVER TRANSPLANT CANDIDATES WITH RENAL DYSFUNCTION: IMPORTANCE OF CREATININE LEVELS, DIALYSIS, AND ORGAN QUALITY IN SURVIVAL.

Tanriover B, MacConmara MP, Parekh J, Arce C, Zhang S, Gao A, Mufti A, Levea SL, Sandikci B, Ayvaci MU, Ariyamuthu VK, Hwang C, Mohan S, Mete M, Vazquez MA, Marrero JA.

Kidney Int Rep. 2016 Nov;1(4):221-229. Epub 2016 Aug 3.

31.

Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis.

Simmons O, Fetzer DT, Yokoo T, Marrero JA, Yopp A, Kono Y, Parikh ND, Browning T, Singal AG.

Aliment Pharmacol Ther. 2017 Jan;45(1):169-177. doi: 10.1111/apt.13841. Epub 2016 Nov 8.

32.

Mailed Outreach Program Increases Ultrasound Screening of Patients With Cirrhosis for Hepatocellular Carcinoma.

Singal AG, Tiro JA, Marrero JA, McCallister K, Mejias C, Adamson B, Bishop WP, Santini NO, Halm EA.

Gastroenterology. 2017 Feb;152(3):608-615.e4. doi: 10.1053/j.gastro.2016.10.042. Epub 2016 Nov 5.

33.

An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis.

Atiq O, Tiro J, Yopp AC, Muffler A, Marrero JA, Parikh ND, Murphy C, McCallister K, Singal AG.

Hepatology. 2017 Apr;65(4):1196-1205. doi: 10.1002/hep.28895. Epub 2016 Dec 19.

34.

Estimating Emissions of Toxic Hydrocarbons from Natural Gas Production Sites in the Barnett Shale Region of Northern Texas.

Marrero JE, Townsend-Small A, Lyon DR, Tsai TR, Meinardi S, Blake DR.

Environ Sci Technol. 2016 Oct 4;50(19):10756-10764. Epub 2016 Sep 15.

PMID:
27580823
35.

Patient-reported barriers are associated with lower hepatocellular carcinoma surveillance rates in patients with cirrhosis.

Farvardin S, Patel J, Khambaty M, Yerokun OA, Mok H, Tiro JA, Yopp AC, Parikh ND, Marrero JA, Singal AG.

Hepatology. 2017 Mar;65(3):875-884. doi: 10.1002/hep.28770. Epub 2016 Oct 1.

36.

Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study.

Marrero JA, Kudo M, Venook AP, Ye SL, Bronowicki JP, Chen XP, Dagher L, Furuse J, Geschwind JH, de Guevara LL, Papandreou C, Takayama T, Sanyal AJ, Yoon SK, Nakajima K, Lehr R, Heldner S, Lencioni R.

J Hepatol. 2016 Dec;65(6):1140-1147. doi: 10.1016/j.jhep.2016.07.020. Epub 2016 Jul 25.

PMID:
27469901
37.

Hospital Volume and Survival After Hepatocellular Carcinoma Diagnosis.

Mokdad AA, Zhu H, Marrero JA, Mansour JC, Singal AG, Yopp AC.

Am J Gastroenterol. 2016 Jul;111(7):967-75. doi: 10.1038/ajg.2016.181. Epub 2016 May 10.

PMID:
27166130
38.

Regional differences in sorafenib-treated patients with hepatocellular carcinoma: GIDEON observational study.

Kudo M, Lencioni R, Marrero JA, Venook AP, Bronowicki JP, Chen XP, Dagher L, Furuse J, Geschwind JF, Ladrón de Guevara L, Papandreou C, Sanyal AJ, Takayama T, Yoon SK, Nakajima K, Lehr R, Heldner S, Ye SL.

Liver Int. 2016 Aug;36(8):1196-205. doi: 10.1111/liv.13096. Epub 2016 Apr 1.

PMID:
26901163
39.

TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice: Final Analysis of GIDEON.

Geschwind JF, Kudo M, Marrero JA, Venook AP, Chen XP, Bronowicki JP, Dagher L, Furuse J, Ladrón de Guevara L, Papandreou C, Sanyal AJ, Takayama T, Ye SL, Yoon SK, Nakajima K, Lehr R, Heldner S, Lencioni R.

Radiology. 2016 May;279(2):630-40. doi: 10.1148/radiol.2015150667. Epub 2016 Jan 8.

PMID:
26744927
40.

The Doylestown Algorithm: A Test to Improve the Performance of AFP in the Detection of Hepatocellular Carcinoma.

Wang M, Devarajan K, Singal AG, Marrero JA, Dai J, Feng Z, Rinaudo JA, Srivastava S, Evans A, Hann HW, Lai Y, Yang H, Block TM, Mehta A.

Cancer Prev Res (Phila). 2016 Feb;9(2):172-9. doi: 10.1158/1940-6207.CAPR-15-0186. Epub 2015 Dec 28.

41.

ESI-LC-MS Method for Haptoglobin Fucosylation Analysis in Hepatocellular Carcinoma and Liver Cirrhosis.

Zhang Y, Zhu J, Yin H, Marrero J, Zhang XX, Lubman DM.

J Proteome Res. 2015 Dec 4;14(12):5388-95. doi: 10.1021/acs.jproteome.5b00792. Epub 2015 Nov 3.

42.

Mass Spectrometric N-Glycan Analysis of Haptoglobin from Patient Serum Samples Using a 96-Well Plate Format.

Zhu J, Wu J, Yin H, Marrero J, Lubman DM.

J Proteome Res. 2015 Nov 6;14(11):4932-9. doi: 10.1021/acs.jproteome.5b00662. Epub 2015 Oct 13.

43.

Mass-Selected Site-Specific Core-Fucosylation of Serum Proteins in Hepatocellular Carcinoma.

Yin H, Tan Z, Wu J, Zhu J, Shedden KA, Marrero J, Lubman DM.

J Proteome Res. 2015 Nov 6;14(11):4876-84. doi: 10.1021/acs.jproteome.5b00718. Epub 2015 Oct 2.

44.

Two enzymes with redundant fructose bisphosphatase activity sustain gluconeogenesis and virulence in Mycobacterium tuberculosis.

Ganapathy U, Marrero J, Calhoun S, Eoh H, de Carvalho LPS, Rhee K, Ehrt S.

Nat Commun. 2015 Aug 10;6:7912. doi: 10.1038/ncomms8912.

45.

Coumarin heterocyclic derivatives: chemical synthesis and biological activity.

Medina FG, Marrero JG, Macías-Alonso M, González MC, Córdova-Guerrero I, Teissier García AG, Osegueda-Robles S.

Nat Prod Rep. 2015 Sep 23;32(10):1472-507. doi: 10.1039/c4np00162a. Review.

PMID:
26151411
46.

Integrating Source Apportionment Tracers into a Bottom-up Inventory of Methane Emissions in the Barnett Shale Hydraulic Fracturing Region.

Townsend-Small A, Marrero JE, Lyon DR, Simpson IJ, Meinardi S, Blake DR.

Environ Sci Technol. 2015 Jul 7;49(13):8175-82. doi: 10.1021/acs.est.5b00057.

PMID:
26148556
47.

Hepatocellular carcinoma tumor board: making sense of the technologies.

Abou-Alfa GK, Marrero J, Renz J, Lencioni R.

Am Soc Clin Oncol Educ Book. 2015:e213-20. doi: 10.14694/EdBook_AM.2015.35.e213. Review.

48.

Recovery of Nickel and Cobalt from Laterite Tailings by Reductive Dissolution under Aerobic Conditions Using Acidithiobacillus Species.

Marrero J, Coto O, Goldmann S, Graupner T, Schippers A.

Environ Sci Technol. 2015 Jun 2;49(11):6674-82. doi: 10.1021/acs.est.5b00944. Epub 2015 May 14.

PMID:
25923144
49.

Response to Zanini et al.

Ahn J, Marrero J, Reddy RK.

Am J Gastroenterol. 2015 Apr;110(4):600. doi: 10.1038/ajg.2015.60. No abstract available.

PMID:
25853203
50.

ACG clinical guideline: the diagnosis and management of focal liver lesions.

Marrero JA, Ahn J, Rajender Reddy K; Americal College of Gastroenterology.

Am J Gastroenterol. 2014 Sep;109(9):1328-47; quiz 1348. doi: 10.1038/ajg.2014.213. Epub 2014 Aug 19.

PMID:
25135008

Supplemental Content

Loading ...
Support Center